The Advanced Addiction Psychopharmacology Course
We will be coming together virtually in 2021!
The live webinar Q&A session for this virtual course will be held on Saturday, November 6, 2021 and Saturday, November 13, 2021.
Who Should Attend?
This course is designed for physicians and other health care professionals who have a foundation in prescribing medication for patients with substance use disorders, including those with co-occurring psychiatric conditions, but would like a deeper understanding of these pharmacotherapies.
This course is designed for learners with a foundational knowledge of addiction psychiatry. Learners who attend this activity will receive a more in-depth educational experience in addiction psychopharmacology.
After participating in this course, learners should be able to:
- Describe how to use methadone, buprenorphine and naltrexone in clinical practice for the treatment of opioid use disorders.
- Describe medication treatments for alcohol use disorders.
- Determine when to use varenicline, bupropion, and nicotine replacement therapy (NRT) for treatment of nicotine use disorders.
- Discuss new evidence for medication treatments for cocaine and methamphetamine use disorder.
- Discuss new evidence for medication treatments for cannabis use disorder.
- Discuss medication approaches for the treatment of sedative-hypnotic use disorder.
- List evidence-based options for anti-depressant and anti-anxiety pharmacotherapy when treating patients with a co-occurring substance use disorder.
- Discuss evidence-based pharmacotherapy for treatment of ADHD with co-occurring substance use disorders.
- Discuss the pharmacotherapy of bipolar disorder in patients with co-occurring substance use disorder.
ADHD Pharmacotherapy with Co-Occurring Substance Use Disorder
Evidence vs. Assumptions
Alcohol Use Disorder Pharmacotherapy
From Detox to Relapse Prevention; Medication Treatments for AUD
Anti-Depressant and Anti-Anxiety Pharmacotherapy with Co-Occurring Substance Use Disorder
Evidence-Based Medication Options
Bipolar Disorder Pharmacotherapy with Co-Occurring Substance Use Disorder
Co-Morbidity is More Common Than Not
Cannabis Use Disorder Pharmacotherapy
Promising Approaches on the Horizon
Nicotine Use Disorder Pharmacotherapy
An Underused Arsenal: Varenicline, Bupropion, and NRT
Opioid Use Disorder Pharmacotherapy
How to use Methadone, Buprenorphine and IM-Naltrexone (MOUD) in Clinical Practice
Sedative-Hypnotic Use Disorder Pharmacotherapy
Inpatient and Outpatient Medication Approaches
Stimulant Use Disorder Pharmacotherapy
Clinical Effects and Treatment Issues